Renal osteodystrophy

Journal of the American Academy of Orthopaedic Surgeons

Volumn 14, Issue 5, 2006, Pages 303-311

  Tejwani, Nirmal C ^a,b   Schachter, Aaron K ^a   Immerman, Igor ^a   Achan, Pramod ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

BLOOD; BONE; BONE DENSITY; HIP ARTHROPLASTY; HIP OSTEOARTHRITIS; HIP PROSTHESIS; HUMAN; INFECTION; KIDNEY; PATHOLOGY; PATHOPHYSIOLOGY; RENAL OSTEODYSTROPHY; REVIEW; SECRETION;

ARTHROPLASTY, REPLACEMENT, HIP; BONE AND BONES; BONE DENSITY; HIP PROSTHESIS; HUMANS; KIDNEY; OSTEOARTHRITIS, HIP; PARATHYROID HORMONE; PROSTHESIS-RELATED INFECTIONS; RENAL OSTEODYSTROPHY;

EID: 33749044223     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/00124635-200605000-00006     Document Type: Review

References (65)

1. Bardin T: Musculoskeletal manifestations of chronic renal failure. Curr Opin Rheumatol 2003;15:48-54.
2. 2003 USRDS Annual Report Atlas. Minneapolis, MN: United States Renal Data System, 2003. Available at http://www.usrds.org/atlas_2003.htm. Accessed March 20, 2006.
3. 2005 USRDS Annual Data Report Atlas. Minneapolis, MN: United States Renal Data System, 2005. Available at http://www.usrds.org/atlas_2005.htm. Accessed March 20, 2006.
4. Cannata Andia JB: Adynamic bone and chronic renal failure: An overview. Am J Med Sci 2000,320:81-84.
5. Sherrard DJ, Hercz G, Pei Y, Segre G: The aplastic form of renal osteodystrophy. Nephrol Dial Transplant 1996,11(suppl 3):29-31.
6. Bushinsky DA: Bone disease in moderate renal failure: Cause, nature and prevention. Annu Rev Med 1997;48:167-176.
7. Murray WR: Hip problems associated with organ transplants. Clin Orthop Relat Res 1973;90:57-69.
8. Bewick M, Stewart PH, Rudge C, Farrand C, McColl I: Avascular necrosis of bone in patients undergoing renal allotransplantation. Clin Nephrol 1976;5:66-72.
9. Sherrard DJ, Hercz G, Pei Y, et al: The spectrum of bone disease in end-stage renal failure: An evolving disorder. Kidney Int 1993;43:436-442.
10. Ho LT, Sprague SM: Percutaneous bone biopsy in the diagnosis of renal osteodystrophy. Semin Nephrol 2002;22:268-275.
11. Hulth A, Olerud S: Tetracycline labelling of growing bone. Acta Soc Med Ups 1962;67:219-231.
12. Frst HM, Villanueva AR, Ramser JR, Ilnicki L: Bone biodynamics in 39 osteoporotic cases measured by tetracycline labelling [German]. Internist (Berl) 1966;7:572-578.
13. Deeb S, Herrmann HJ: Tetracycline-labelling as a method for detecting the bone demineralization of parathormone-treated rats. Acta Histochem 1974;50:35-42.
14. Hoyland JA, Picton ML: Cellular mechanisms of renal osteodystrophy. Kidney Int Suppl 1999;73:S8-13.
15. Llach F, Felsenfeld AJ, Coleman MD, Keveney JJ Jr, Pederson JA, Medlock TR: The natural course of dialysis osteomalacia. Kidney Int Suppl 1986;18:S74-S79.
16. Goodman WC, Coburn JW, Slatopolsky E, Salusky IB, Quarles LD: Renal osteodystrophy in adults and children, in Favus M (ed): Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, ed 3. Washington, DC: American Society for Bone and Mineral Research, 2003, pp 341-360.
17. Coburn JWS, Slatopolsky E: Vitamin D, parathyroid hormone, and the renal osteodystrophies, in Brenner BR (ed): The Kidney, ed 7. Philadelphia, PA: WB Saunders, 1990, p 2076.
18. Stickler GB, Bergen BJ: A review: Short stature in renal disease. Pediatr Res 1973;7:978-982.
19. Loder RT, Hensinger RN: Slipped capital femoral epiphysis associated with renal failure osteodystrophy. J Pediatr Orthop 1997;17:205-211.
20. Oppenheim WL, Bowen RE, McDonough PW, Funahashi TT, Salusky IB: Outcome of slipped capital femoral epiphysis in renal osteodystrophy. J Pediatr Orthop 2003;23:169-174.
21. Mehls O: Renal osteodystrophy in children: Etiology and clinical aspects, in Fine RG (ed): Endstage Renal Disease in Children. Philadelphia, PA: WB Saunders, 1984, pp 227-250.
22. Lima EM, Goodman WG, Kuizon BD, et al: Bone density measurements in pediatric patients with renal osteodystrophy. Pediatr Nephrol 2003;18:554-559.
23. Gipstein RM, Coburn JW, Adams DA, et al: Calciphylaxis in man: A syndrome of tissue necrosis and vascular calcification in 11 patients with chronic renal failure. Arch Intern Med 1976;136:1273-1280.
24. Rodino MA, Shane E: Osteoporosis after organ transplantation. Am J Med 1998;104:459-469.
25. Shapiro R: Radiologic aspects of renal osteodystrophy. Radiol Clin North Am 1972;10:557-568.
26. Reginald AJ, Falasca GF, Pappu R, McKnight B, Agha A: Musculoskeletal manifestations of osteomalacia: Report of 26 cases and literature review. Semin Arthritis Rheum 1999;28:287-304.
27. Murphey MD, Sartoris DJ, Quale JL, Pathria MN, Martin NL: Musculoskeletal manifestations of chronic renal insufficiency. Radiographics 1993;13:357-379.
28. Mankin HJ: Rickets, osteomalacia, and renal osteodystrophy: An update. Orthop Clin North Am 1990;21:81-96.
29. Mankin HJ: Rickets, osteomalacia, and renal osteodystrophy: Part II. J Bone Joint Surg Am 1974;56:352-386.
30. Pugh DG: Suhperiosteal resorption of bone: A roentgenologic manifestation of primary hyperparathyroidism and renal osteodystrophy. Am J Roentgenol Radium Ther Nucl Med 1951;66:577-586.
31. Steinbach HL, Noetzli M: Roentgen appearance of the skeleton in osteomalacia and rickets. Am J Roentgenol Radium Ther Nucl Med 1964;91:955-972.
32. Portale AA, Halloran BP, Morris RC Jr: Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus: Implications for the renal production of 1,25-dihydroxyvitamin D. J Clin Invest 1987;80:1147-1154.
33. Portale AA, Halloran BP, Morris RC Jr: Physiologic regulation of the serum concentration of 1,25-dihydroxy-vitamin D by phosphorus in normal men. J Clin Invest 1989;83:1494-1499.
34. Barsotti G, Guiducci A, Ciardella F, Giovannetti S: Effects on renal function of a low-nitrogen diet supplemented with essential amino acids and ketoanalogues and of hemodialysis and free protein supply in patients with chronic renal failure. Nephron 1981;27:113-117.
35. Coburn JW, Henry DA: Renal osteodystrophy. Adv Intern Med 1984;30:387-424.
36. Baker LR, Abrams L, Roe CJ, et al: 1,25(OH)2D3 administration in moderate renal failure: A prospective double-blind trial. Kidney Int 1989;35:661-669.
37. Baker LR, Abrams SM, Roe CJ, et al: Early therapy of renal bone disease with calcitriol: A prospective double-blind study. Kidney Int Suppl 1989;27:S140-S142.
38. Baker LR: Prevention of renal osteodystrophy. Miner Electrolyte Metab 1991;17:240-249.
39. Hoen B, Renoult E, Jonon B, Kessler M: Septicemia due to Yersinia enterocolitica in a long-term hemodialysis patient alter a single desferrioxamine administration. Nephron 1988;50:378-379.
40. Gallant T, Freedman MH, Vellend H, Francombe WH: Yersinia sepsis in patients with iron overload treated with deferoxamine. N Engl J Med 1986;314:1643.
41. Augat P, Rapp S, Claes L: A modified hip screw incorporating injected cement for the fixation of osteoporotic trochanteric fractures. J Orthop Trauma 2002;16:311-316.
42. Moroni A, Orienti L, Stea S, Visentin M: Improvement of the bone-pin interface with hydroxyapatite coating: An in vivo long-term experimental study. J Orthop Trauma 1996;10:236-242.
43. Moroni A, Faldini C, Marchetti S, Manca M, Consoli V, Giannini S: Improvement of the bone-pin interface strength in osteoporotic bone with use of hydroxyapatite-coated tapered external-fixation pins: A prospective, randomized clinical study of wrist fractures. J Bone Joint Surg Am 2001;83:717-721.
44. Moroni A, Faldini C, Rocca M, Stea S, Giannini S: Improvement of the bonescrew interface strength with hydroxyapatite-coated and titanium-coated AO/ASIF cortical screws. J Orthop Trauma 2002;16:257-263.
45. Kwon BK, Goertzen DJ, O'Brien PJ, Broekhuyse HM, Oxland TR: Biomechanical evaluation of proximal humeral fracture fixation supplemented with calcium phosphate cement. J Bone Joint Surg Am 2002;84:951-961.
46. Ferguson SJ, Winkler F, Nolte LP: Anterior fixation in the osteoporotic spine: Cut-out and pullout characteristics of implants. Eur Spine J 2002;11:527-534.
47. Hagglund G: The contralateral hip in slipped capital femoral epiphysis. J Pediatr Orthop B 1996;5:158-161.
48. Wells D, King JD, Roe TF, Kaufman FR: Review of slipped capital femoral epiphysis associated with endocrine disease. J Pediatr Oithop 1993;13:610-614.
49. Bucci JR, Oglesby RJ, Agodoa LY, Abbott KC: Hospitalizations for total hip arthroplasty after renal transplantation in the United States. Am J Transplant 2002;2:999-1004.
50. Spencer JD, Brookes M: Avascular necrosis and the blood supply of the femoral head. Clin Orthop Relat Res 1988;235:127-140.
51. Spencer JD, Maisey M: A prospective scintigraphic study of avascular necrosis of bone in renal transplant patients. Clin Orthop Relat Res 1985;194:125-135.
52. Parfrey PS, Farge D, Parfrey NA, Hanley JA, Guttman RD: The decreased incidence of aseptic necrosis in renal transplant recipients: A case control study. Transplantation 1986;41:182-187.
53. Cheng EY, Klibanoff JE, Robinson HJ, Bradford DS: Total hip arthroplasty with cement after renal transplantation: Long-term results. J Bone Joint Surg Am 1995;77:1535-1542.
54. Murzic WJ, McCollum DE: Hip arthroplasty for osteonecrosis after renal transplantation. Clin Orthop Relat Res 1994;299:212-219.
55. Toomey HE, Toomey SD: Hip arthroplasty in chronic dialysis patients. J Arthroplasty 1998;13:647-652.
56. Vautour LM, Melton LJ III, Clarke BL, Achenbach SJ, Oberg AL, McCarthy JT: Long-term fracture risk following renal transplantation: A population-based study. Osteoporos Int 2004;15:160-167.
57. Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T: Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 1999;33:287-293.
58. Ball AM, Gillen DL, Sherrard D, et al: Risk of hip fracture among dialysis and renal transplant recipients. JAMA 2002;288:3014-3018.
59. Alem AM, Sherrard DJ, Gillen DL, et al: Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 2000;58:396-399.
60. Abbott KC, Oglesby RJ, Hypolite IO, et al: Hospitalizations for fractures after renal transplantation in the United States. Ann Epidemiol 2001;11:450-457.
61. Abbott KC, Duran M, Hypolite I, Ko CW, Jones CA, Agodoa LY: Hospitalizations for bacterial endocarditis after renal transplantation in the United States. J Nephrol 2001;14:353-360.
62. Abbott KC, Oliver JD III, Hypolite I, et al: Hospitalizations for bacterial septicemia after renal transplantation in the United States. Am J Nephrol 2001;21:120-127.
63. Abbott KC, Napier MG, Agodoa LY: Hospitalizations for bacterial septicemia in patients with end stage renal disease due to diabetes on the renal transplant waiting list. J Nephrol 2002;15:248-254.
64. Teehan GS, Bahdouch D, Ruthazer R, Balakrishnan VS, Snydman DR, Jaber BL: Iron storage indices: Novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy. Clin Infect Dis 2004;38:1090-1094.
65. Tveit DJ, Hypolite IO, Poropatich RK, et al: Hospitalizations for bacterial pneumonia after renal transplantation in the United States. J Nephrol 2002;15:255-262.